Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
10/2010
10/14/2010US20100261765 Mineralocorticoid receptor modulators
10/14/2010US20100261758 Heterocyclic amides for use as pharmaceuticals
10/14/2010US20100261754 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260709 Organic compounds and their uses
10/14/2010CA2757912A1 Compounds that suppress cancer cells and exhibit antitumor activity
10/14/2010CA2757368A1 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/14/2010CA2755338A1 Method for recovery/reuse of n-oxyl compound
10/13/2010EP2239254A1 Benzylpiperizine compound
10/13/2010EP1833817B1 Synthesis of ccr5 receptor antagonists
10/13/2010CN1916760B Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition
10/13/2010CN101857565A Preparation method of 3-amino-4-piperidone and corresponding derivative thereof
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812035 Psychological disorders; antidepressants; anxiolytic agents; sexual disorders
10/12/2010US7812033 Method for increasing the activity of acid-β-galactosidase
10/12/2010US7812019 Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
10/12/2010US7812017 such as 1-(Phenylsulfonyl)-4-(piperazin-1-ylmethyl)-1H- indole, hydrochloride, used as dietetics, selective serotonin receptor antagonists or in cosmetics
10/07/2010WO2010114996A2 Method for preparing cha-type molecular sieves using novel structure directing agents
10/07/2010WO2010114181A1 Acrylamide compounds and the use thereof
10/07/2010WO2010112865A1 5-ht receptor modulating compounds
10/07/2010WO2010111948A1 Arylmethylamine compounds, preparation methods and pharmaceutical uses thereof
10/07/2010US20100256382 Tri-aryl compounds and compositions comprising the same
10/07/2010US20100256367 Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives
10/07/2010US20100256359 Hetero isonipecotic modulators of vanilloid vr1 receptor
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256189 Piperidine derivative
10/07/2010US20100256186 Sulfonyl-piperidin-4-yl methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
10/07/2010US20100256163 Disubstituted phenylpiperdines/piperazines as modulators of dopamine neurotransmission
10/07/2010US20100256162 Piperazine and Piperidine Derivatives
10/07/2010US20100256150 Cyclic hydroxylamine as psychoactive compounds
10/07/2010US20100256147 Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256126 Piperidine derivatives as nk3 receptor antagonists
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256111 Therapeutic agents useful for treating pain
10/07/2010CA2757726A1 Acrylamide compounds and the use thereof
10/07/2010CA2757476A1 Method for preparing cha-type molecular sieves using novel structure directing agents
10/07/2010CA2757106A1 5-ht receptor modulating compounds
10/06/2010EP2236492A1 Novel dicarboxylic amino acid derivatives and the use thereof in the treatment of neurodegenerative diseases
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010EP2234975A1 Process for producing pipecolic-2-acid-2 ',6'-xylidide useful as an intermediate for the preparation of local anesthetics
10/06/2010EP2234974A1 Process for the preparation of (s)-1-alkyl-2',6'-pipecoloxylidide compound
10/06/2010EP2234973A1 Anthelmintic agents and their use
10/06/2010EP2234972A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands
10/06/2010EP2234971A1 Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity
10/06/2010EP2234616A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/06/2010CN1665501B Novel compounds as opioid receptor modulators
10/06/2010CN101851192A Method for synthesizing nimodipine by cyclic compounds as solvents
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101851143A Method for alkylating amine and amino acid
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807695 Treating skin wrinkles, especially expression wrinkles such as crow's feet; muscle relaxants; 6-{2-[4-(3-phenylpropyl)-piperidin-1-yl]ethyl}undecan-6-ol for example
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010CA2549832C Amlodipine gentisate and a method of its preparation
09/2010
09/30/2010WO2010111353A1 N-substituted piperidine derivatives as serotonin receptor agents
09/30/2010WO2010110374A1 Agent for enhancing hypoglycemic activity
09/30/2010WO2010108608A1 Substituted piperidines as par-1 antagonists
09/30/2010WO2009127949A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
09/30/2010US20100249424 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
09/30/2010US20100249423 Tolperisone controlled release tablet
09/30/2010US20100249422 Acylation reaction of hydroxyl group
09/30/2010US20100249421 Biphenyl compounds useful as muscarinic receptor antagonists
09/30/2010US20100249401 Process for the preparation of sterically hindered nitroxyl ethers
09/30/2010US20100249350 Hyperbranched polymer having nitroxyl group
09/30/2010US20100249163 Renin inhibitors
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/30/2010US20100249075 Substituted tetralins as selective estrogen receptor-beta agonists
09/30/2010US20100249049 Arylalkylamine compound and process for preparing the same
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010DE19831712B4 Fluorcyclohexan-Derivate und flüssigkristallines Medium Fluorocyclohexane derivatives and liquid crystalline medium
09/30/2010DE102009014484A1 Substituierte Piperidine Substituted piperidines
09/30/2010CA2756005A1 Substituted piperidines as par-1 antagonists
09/29/2010EP2231687A2 Novel derivatives of acyl cyanopyrrolidines
09/29/2010EP2231601A2 Glycine transporter-1 inhibitors
09/29/2010EP2231600A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231599A1 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
09/29/2010EP1893200B1 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors
09/29/2010EP1615889B1 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010CN1865259B Process for preparing piperidine derivative
09/28/2010US7803813 selective serotonin receptor agonists, such as 2-chloro-4-fluoro-N-(3-(1-methylpiperidin-4-ylamino)phenyl)benzamide fumarate, used fot the treatment or prevention of neuronal protein extravasation and/or headaches
09/28/2010US7803812 Biphenyl compounds useful as muscarinic receptor antagonists
09/28/2010US7803795 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis
09/28/2010US7803585 Process for preparing 2-Hydroxy-4-Substituted Pyridines
09/23/2010WO2010106081A1 Piperidine derivatives as nk3 receptor antagonists
09/23/2010WO2009127948A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors
09/23/2010US20100240710 Use of Pyridoxamine to Treat and/or Prevent Disease Processes
09/23/2010US20100240704 Method of modulating stress-activated protein kinase system
09/23/2010US20100240703 Oxyimino compounds and the use thereof
09/23/2010US20100240702 Benzimidazolone Chymase Inhibitors
09/23/2010US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors
09/23/2010US20100240654 Hydrazide derivatives
09/23/2010CA2749650A1 Piperidine derivatives as nk3 receptor antagonists
09/22/2010EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
09/22/2010EP2229373A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
09/22/2010EP2229363A1 Renin inhibitors
09/22/2010EP2229362A1 Piperazines as anti-obesity agents
09/22/2010EP2229167A1 Mineralocorticoid receptor modulators
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 380